NCT06629831View on ClinicalTrials.gov

Systemic Inflammatory Biomarkers in Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

September 27, 2024

Conditions
Ovarian Cancer
Interventions
OTHER

group with complications

Complications in patients undergoing cytoreduction surgery for ovarian cancer

OTHER

group without complications

Complications in patients undergoing cytoreduction surgery for ovarian cancer

Trial Locations (1)

Unknown

BasaksehiCam and Sakura City Hospital, Istanbul

All Listed Sponsors
lead

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

OTHER_GOV